Search research articles
Contact Us
Filters
Showing results (31-40 of 419) with videos related to
Page
of 42
Sort By:
Kidney International
|
November 2, 2011
Short-term effects of vitamin D receptor activation on serum creatinine, creatinine generation, and glomerular filtration
Matthew R Weir
Transplantation
|
March 14, 2015
Is there an optimal strategy for pretransplant cardiovascular screening?
Matthew R Weir
Seminars in Nephrology
|
March 3, 2026
Kidney Protection Options in 2025: Are Renin-Angiotensin System Inhibitors Still Needed?
Matthew R Weir
The Journal of Family Practice
|
August 25, 2021
Decision Points in the Management of Patients with Diabetic Kidney Disease
Matthew R Weir
Hypertension (Dallas, Tex. : 1979)
|
July 14, 2010
Hypervolemia and blood pressure: powerful indicators of increased mortality among hemodialysis patients
Matthew R Weir
Postgraduate Medicine
|
May 28, 2019
Renal effects of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and renal impairment
Matthew R Weir
Journal of Clinical Hypertension (Greenwich, Conn.)
|
March 11, 2004
Microalbuminuria in type 2 diabetics: an important, overlooked cardiovascular risk factor
Matthew R Weir
American Journal of Hypertension
|
April 20, 2005
The role of combination antihypertensive therapy in the prevention and treatment of chronic kidney disease
Matthew R Weir
Current Hypertension Reports
|
September 3, 2004
Clinical trials report. Adverse prognostic significance of new diabetes in treated hypertensive subjects
Matthew R Weir
Kidney International
|
July 16, 2011
Acute fall in glomerular filtration rate with renin-angiotensin system inhibition: a biomeasure of therapeutic success?
Matthew R Weir
Page
of 42
Search research articles
Search
Showing results (31-40 of 419) with videos related to
Sort By:
Page
of 42
Kidney International
|
November 2, 2011
Short-term effects of vitamin D receptor activation on serum creatinine, creatinine generation, and glomerular filtration
Matthew R Weir
Transplantation
|
March 14, 2015
Is there an optimal strategy for pretransplant cardiovascular screening?
Matthew R Weir
Seminars in Nephrology
|
March 3, 2026
Kidney Protection Options in 2025: Are Renin-Angiotensin System Inhibitors Still Needed?
Matthew R Weir
The Journal of Family Practice
|
August 25, 2021
Decision Points in the Management of Patients with Diabetic Kidney Disease
Matthew R Weir
Hypertension (Dallas, Tex. : 1979)
|
July 14, 2010
Hypervolemia and blood pressure: powerful indicators of increased mortality among hemodialysis patients
Matthew R Weir
Postgraduate Medicine
|
May 28, 2019
Renal effects of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and renal impairment
Matthew R Weir
Journal of Clinical Hypertension (Greenwich, Conn.)
|
March 11, 2004
Microalbuminuria in type 2 diabetics: an important, overlooked cardiovascular risk factor
Matthew R Weir
American Journal of Hypertension
|
April 20, 2005
The role of combination antihypertensive therapy in the prevention and treatment of chronic kidney disease
Matthew R Weir
Current Hypertension Reports
|
September 3, 2004
Clinical trials report. Adverse prognostic significance of new diabetes in treated hypertensive subjects
Matthew R Weir
Kidney International
|
July 16, 2011
Acute fall in glomerular filtration rate with renin-angiotensin system inhibition: a biomeasure of therapeutic success?
Matthew R Weir
Page
of 42